Cocrystal Pharma Inc reports results for the quarter ended in June - Earnings Summary

Cocrystal Pharma

15/08/2022 14:31

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 25 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 4 cents per share.
    * Reported revenue was zero​; analysts expected $83.33
thousand. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had risen by 13.3% this
quarter and
lost 28.6% so far this year.
    * The company reported a quarterly loss of $24.43 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.04          -0.25          Missed
 Mar. 31 2022      -0.03          -0.04          Missed
 Dec. 31 2021      -0.04          -0.04          Met
 Sep. 30 2021      -0.04          -0.04          Met